SCHEMBL760073

SCHEMBL760073

Nc1n[nH]c2c([N+](=O)[O-])cccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
CHEK1 O14757 1/20 0.51
FLT3 P36888 1/20 0.51
PLK3 Q9H4B4 1/20 0.51
MAPT P10636 4/20 0.51
NOS1 P29475 3/20 0.51
ALDH1A1 P00352 3/20 0.51
KDM4E B2RXH2 2/20 0.51
MEN1 O00255 2/20 0.51
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
TSHR P16473 2/20 0.51
CYP2C19 P33261 2/20 0.51
NOS2 P35228 2/20 0.51
BLM P54132 2/20 0.51
KMT2A Q03164 2/20 0.51
MAPK1 P28482 2/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX15 P16050 1/20 0.51
THRB P10828 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30799054 0.81 MAPT (0.50) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL30799435 0.81 MAPT (0.50) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL13122675 0.81 MAPT (0.55) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL3004143 0.81 MAPT (0.50) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL31114379 0.81 MAPT (0.58) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL499421 0.81 MAPT (0.58) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL27143397 0.81 MAPT (0.50) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL3534877 0.79 MAPT (0.48) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL11728097 0.78 PARP1 (0.51) TDP1MAPTNOS1ALDH1A1KDM4E
SCHEMBL27174860 0.78 MAPT (0.47) TDP1MAPTNOS1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 US disclosed
EP-2001480-A2 INDAZOLE COMPOUNDS Abbott Laboratories (US) 2008-12-17 EP disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed
WO-2007117465-A2 INDAZOLE COMPOUNDS ABBOTT LABORATORIES (US) 2007-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 TDP1 2027/4885CHEK1 1404/4885FLT3 117/4885
US-20120053345-A1 Indazole Compounds CYP3A43, CYP3A7, UGT1A1 TDP1 2027/4885CHEK1 1404/4885FLT3 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.